ONCO
Onconetix, Inc.
There isn't enough reported data to score ONCO yet.
ONCO Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Unavailable | |
| Unavailable |
ONCO's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
ONCO PE Valuation
ONCO has no meaningful PE right now: it lost money over the past year.
ONCO Forward outlook
There aren't enough analyst estimates for ONCO to show an outlook.
ONCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2025 | -$766,680.00 | +$3,828,845.00 |
| Q2 2025 | -$888,080.00 | +$4,109,920.00 |
| Q1 2025 | -$1,973,700.00 | +$2,293,300.00 |
| Q4 2024 | -$2,801,175.00 | +$921,825.00 |
| Q3 2024 | -$4,595,525.00 | -$2,923,041.56 |
| Q2 2024 | -$4,998,000.00 | -$3,393,516.56 |
| Q1 2024 | -$4,267,000.00 | -$2,407,516.56 |
| Q4 2023 | -$3,723,000.00 | -$1,853,000.00 |
ONCO is still losing money, but far less than before: $766,680.00 per share over the past year, against $4,998,000.00 at its worst in mid-2024.
ONCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $17.1K | -84% |
| Q1 2026 | $21.5K | -79% |
| Q4 2025 | $303.6K | -57% |
| Q3 2025 | $303.7K | -25% |
| Q2 2025 | $106.5K | -85% |
| Q1 2025 | $101.6K | -75% |
ONCO's revenue has slid since its 2024 peak: $17,120 last quarter, down 84% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -15951% | -14134 points |
| Q1 2026 | -47657% | -35288 points |
| Q4 2025 | -422% | +3672 points |
| Q3 2025 | -681% | -31 points |
| Q2 2025 | -1817% | +114 points |
| Q1 2025 | -12369% | -9599 points |
| Q4 2024 | -4094% | N/A |
| Q3 2024 | -650% | N/A |
ONCO's operating margin was −15951% last quarter, down 14133 points from the same quarter a year ago, near the bottom of its range since 2024.
ONCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$921.5K | +$3.4M |
| Q3 2024 | -$1.1M | +$1.9M |
| Q2 2024 | -$3.2M | -$1.4M |
| Q1 2024 | -$5.2M | -$788.7K |
| Q4 2023 | -$4.3M | -$1.5M |
| Q3 2023 | -$3M | -$1.2M |
| Q2 2023 | -$1.8M | +$1.4M |
| Q1 2023 | -$4.4M | -$3.6M |
ONCO has burned cash in almost every quarter: −$6M over the past year, against −$16M the year before.
ONCO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3468% | +218K shares |
| 1 year | +52301% | +224K shares |
| 3 years | +3203857% | +224K shares |
ONCO has 224,277 diluted shares, up 52301% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | $25,527 |
| Q1 2023 | $33,454 |
ONCO Net Leverage
ONCO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ONCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.5 | Oversold |
| Stochastic | 17.9 | Oversold |
ONCO's weekly RSI is 29 (oversold) and its Stochastic is 18 (oversold).
ONCO PE vs Healthcare Sector
ONCO has no meaningful PE right now: it lost money over the past year.
ONCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.05 | 50% below |
| 20 week MA | $7.26 | 58% below |
| 50 week MA | $229.4 | 99% below |
| 100 week MA | $3,385.0 | 100% below |
| 200 week MA | $414,179.2 | 100% below |
ONCO is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
ONCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $97,580,000.0 | $1,751,000.0 | -98% |
| 2023 | $1,751,000.0 | $336,600.0 | -81% |
| 2024 | $336,600.0 | $16,365.1 | -95% |
| 2025 | $16,365.1 | $715.0 | -96% |
| 2026 YTD | $715.0 | $3.03 | -100% |
ONCO has finished every year since 2022 lower, and it's down 100% so far in 2026.